By Sean Muthian, contributor
Want to keep working in translational research but prefer a role away from the bench? Then opportunities abound.
For PhDs who still want to have a hand in translational research, but do not necessarily want to be the ones at the bench, there are many options. There are jobs in regulatory affairs, with the FDA or EMA, and policy work with the NIH. Disease oriented non-profits, such as the American Lung Association, or private foundations, such as the Michael J. Fox Foundation, also commit funds and efforts to accelerate the search for cures. At these organizations, you can improve opportunities for large numbers of translational researchers. In the United States, one of the best resources for staying up to date on news and events, and catching up on policy issues in translational research is the NCATS website. NCATS is the National Center for Advancing Translational Sciences and is part of the NIH. In Europe EATRIS, the European Advanced Translational Research Infrastructure in Medicine, is a similar resource.
There are also clear opportunities on the business side because the labs proficient at generating discoveries are not often adept at turning ideas and some IP into a marketable product. According to an AAAS and Sigma-Aldrich survey of academic translational researchers, 62% of translational researchers believe collaboration with their business school would benefit their work, yet only 13% are in such collaborations now. This highlights a necessary growth of the support network for academic translational researchers. Where can you fit in then? Good options include positions in business development or tech transfer at academic institutes, academic partnership development and management in industry, or as a patent agent at an IP firm.
With these new career options in business and law come some questions: Continue reading




